Tofacitinib Impurity

Product Name
Tofacitinib Impurity
CAS No.
90953-01-8
Chemical Name
Tofacitinib Impurity
Synonyms
Tofacitinib Impurity JT2-I;7H-Pyrrolo[2,3-d]pyrimidin-4-amine, N,N-dimethyl-
CBNumber
CB56226036
Molecular Formula
C8H10N4
Formula Weight
162.19
MOL File
90953-01-8.mol
More
Less

Tofacitinib Impurity Property

Boiling point:
300.6±45.0 °C(Predicted)
Density 
1.27±0.1 g/cm3(Predicted)
pka
13.34±0.20(Predicted)
More
Less

Hazard and Precautionary Statements (GHS)

Tofacitinib Impurity Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Tofacitinib Impurity Suppliers

China 7 Global 7
ANHUI WITOP BIOTECH CO., LTD
Tel
+8615255079626
Email
eric@witopchemical.com
Country
China
ProdList
23556
Advantage
58
Jinan blalong chemical co. LTD
Tel
2710913286@.com
Email
1513643261@qq.com
Country
China
ProdList
14253
Advantage
58
Shenzhen ruikai de biotechnology co., ltd.
Tel
0755-61348847 17820674378
Fax
0755-21016893
Email
2682116078@qq.com
Country
China
ProdList
7844
Advantage
58
Meng Cheng Technology (Shanghai) Co., LTD
Tel
400-820-6829
Email
sales@mitachieve.com
Country
China
ProdList
8864
Advantage
58
SHENZHEN PHYSTANDARD BIO-TECH CO.,LTD
Tel
0755-0755-0755-83725350 13380397412
Fax
0755-28094224
Email
3001280422@qq.com
Country
China
ProdList
9972
Advantage
58
Hubei Ruinuo Pharmaceutical Technology Co., Ltd
Tel
0714-5316360 13165688766
Fax
0714-5316360
Email
123456789@qq.com
Country
China
ProdList
5001
Advantage
58
Shanghai Zerui Biotechnology Co., Ltd.
Tel
021-54580889 18321124657
Fax
021-54580889
Email
731997554@qq.com
Country
China
ProdList
10614
Advantage
58

90953-01-8, Tofacitinib ImpurityRelated Search:

(3R,4R)-N,1,4-trimethyl-N-{7H-pyrrolo[2,3-d]pyrimidin-4-yl}piperidin-3-amine N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine Tofacitinib Impurity 36 6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine 7H-Pyrrolo[2,3-d]pyriMidin-4-aMine, N-Methyl-N-[(3R,4R)-4-Methyl-1-(phenylMethyl)-3-piperidinyl]-7-[(4-Met hylphenyl)sulfonyl]- 1-Piperidinepropanoic acid, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, ethyl ester, (3R,4R)- 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide 3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine Tofacitinib Impurity butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate 3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI) N-(2,6-dimethylphenyl)-2-((2,6-dimethylphenyl)amino)acetamide (3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine 1-BENZYL-N,4-DIMETHYLPIPERIDIN-3-AMINE DIHYDROCHLORIDE Tofacitinib Related Compound Tofacitinib Impurity 45 Tofacitinib Impurity 2

  • Tofacitinib Impurity JT2-I
  • 7H-Pyrrolo[2,3-d]pyrimidin-4-amine, N,N-dimethyl-
  • 90953-01-8